Laurus Labs Q2 net profit surges on 33% rise in revenue
Laurus said it is acquiring 60% stake in Galenvs Sciences Inc., a contract research and development organisation based in Montreal. | Photo Credit: The Hindu Pharmaceutical and biotechnology company Laurus Labs reported a more than twofold increase in consolidated net profit to ₹436.74 crore for the September quarter, driven by a 33% growth in revenue…
Read More “Laurus Labs Q2 net profit surges on 33% rise in revenue” »